CSDX.US CS Diagnostics Corp.

Healthcare Medical Devices USA Stocks
0.0698 USD
Close of Nov 12, 2026
0.0004 0.3980
Market cap
USD 17.4M
P/E
-
P/B
0.03x
ROE
0.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is CSDX.US undervalued?

Graham number

The Graham number of CS Diagnostics Corp. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CS Diagnostics Corp. fundamental analysis

No fundamental analysis for CS Diagnostics Corp. yet.

CS Diagnostics Corp. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CS Diagnostics Corp.

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant protection product; and CS-Protect Hydrogel, a proprietary oncology medical device used in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Cheyenne, …

Full company profile